Form 4: Arteris COO Sells Shares Under 10b5-1 Plan

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 39,831 shares of common stock in multiple transactions on January 2nd and 3rd, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Laurent R. Moll, the Chief Operating Officer of Arteris, Inc., sold a total of 39,831 shares of the company's common stock.
• The sales occurred on January 2nd and 3rd, 2025.
• The transactions were executed under a pre-arranged 10b5-1 trading plan adopted on March 15, 2024.
• On January 2nd, 2025, 2,177 shares were sold at $11.4133 each, 2,130 shares were sold at $11.4133 each, and 18,558 shares were sold at a weighted average price of $10.9501.
• On January 3rd, 2025, 16,966 shares were sold at $12.08 each.
• The sales on January 2nd included shares sold to cover tax liabilities from the release of restricted stock units.
• Following these transactions, Moll's direct ownership of Arteris common stock decreased to 451,761 shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, which is neither positive nor negative for the company's outlook.

Risks

• The sale of a significant number of shares by a company executive could be perceived negatively by the market.

Industry Context

Executive stock sales are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading. The market will likely interpret this as a routine transaction.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to manage their stock sales and avoid insider trading accusations.
• The volume of shares sold is not unusual for an executive exercising stock options or selling shares for tax purposes.
• Comparable companies often see similar transactions by their executives, and the market generally understands these as part of normal compensation and financial planning.

Stakeholder Impact

• The stock sale may have a minor impact on the share price, but it is unlikely to have a significant effect on other stakeholders.

Key Dates

Keywords

Arteris, Laurent R. Moll, insider trading, stock sale, 10b5-1 plan, common stock, executive, share transaction